Lei, M., Overman, M. J., Yao, J., André, T., Lonardi, S., Lenz, H., Aglietta, M., Gelsomino, F., McDermott, R., Wong, K. Y. M., Morse, M. A., Cutsem, E. V., Hendlisz, A., Cardin, D. B., Neyns, B., Hill, A., Krishnamurthy, A., Chen, F., Kochuparambil, S., Jenq, R. R., Abdullaev, S., He, B., Novosiadly, R., Kopetz, S. (2025). Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer. Nature Communications. https://doi.org/10.1038/s41467-025-63960-8